Adobe

STAT+ | Akeso says its closely watched drug improved patient survival in a lung cancer trial

Seen as a rival to Keytruda, the Chinese biotech's ivonescimab has quickly become one of the most closely watched drugs in oncology

By Jonathan Wosen

A major childhood brain cancer network is ending

Today's health news includes what we know about bruised hands and cardiovascular health, the end of NCI childhood brain cancer funding, etc.

By Theresa Gaffney

STAT+ | Health care giants are pushing hard for Congress to extend ACA insurance subsidies

Enhanced Affordable Care Act subsidies that help millions of people buy cheaper health insurance will expire at the end of the year unless Congress acts.

By Daniel Payne